Related references
Note: Only part of the references are listed.Serpin Signatures in Prion and Alzheimer's Diseases
Marco Zattoni et al.
MOLECULAR NEUROBIOLOGY (2022)
Pharmacological inactivation of the prion protein by targeting a folding intermediate
Giovanni Spagnolli et al.
COMMUNICATIONS BIOLOGY (2021)
Tackling prion diseases: a review of the patent landscape
Marco Zattoni et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2021)
Small-molecule modulators of serine protease inhibitor proteins (serpins)
Tahsin F. Kellici et al.
DRUG DISCOVERY TODAY (2021)
Cellular models for discovering prion disease therapeutics: Progress and challenges
Saffire H. Krance et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Glycosylation Tunes Neuroserpin Physiological and Pathological Properties
Cristina Visentin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Detection of prions in skin punch biopsies of Creutzfeldt-Jakob disease patients
Angela Mammana et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
In silico/in vitro screening and hit evaluation identified new phenothiazine anti-prion derivatives
Ludovica Zaccagnini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel regulators of PrP©expression as potential therapeutic targets in prion diseases
Arianna Colini Baldeschi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders
Annalisa Savardi et al.
CHEM (2020)
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints
Eric Vallabh Minikel et al.
NUCLEIC ACIDS RESEARCH (2020)
Generation, optimization and characterization of novel anti-prion compounds
Andrea Altieri et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Novel screening approaches for human prion diseases drug discovery
Fabio Moda et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Isobologram Analysis: A Comprehensive Review of Methodology and Current Research
Ruo-yue Huang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Antisense oligonucleotides extend survival of prion-infected mice
Gregory J. Raymond et al.
JCI INSIGHT (2019)
Prions, prionoids and protein misfolding disorders
Claudia Scheckel et al.
NATURE REVIEWS GENETICS (2018)
Increased Serpina3n release into circulation during glucocorticoid-mediated muscle atrophy
Marine Gueugneau et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Mathias Jucker et al.
NATURE NEUROSCIENCE (2018)
SerpinA3N is a novel hypothalamic gene upregulated by a high-fat diet and leptin in mice
Domenico Sergi et al.
GENES AND NUTRITION (2018)
CHI3L1 and CHI3L2 overexpression in motor cortex and spinal cord of sALS patients
C. Sanfilippo et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2017)
Remarkable increases of 1-antichymotrypsin in brain tissues of rodents during prion infection
Cao Chen et al.
PRION (2017)
Differential overexpression of SERPINA3 in human prion diseases
S. Vanni et al.
SCIENTIFIC REPORTS (2017)
Elucidating the function of the prion protein
Giuseppe Legname
PLOS PATHOGENS (2017)
STRAND-SPECIFIC RNA-SEQUENCING ANALYSIS OF MULTIPLE SYSTEM ATROPHY BRAIN TRANSCRIPTOME
J. D. Mills et al.
NEUROSCIENCE (2016)
Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques
Maura Barbisin et al.
BMC GENOMICS (2014)
Successes and Challenges in Phenotype-Based Lead Discovery for Prion Diseases
Sina Ghaemmaghami et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A Test for Creutzfeldt-Jakob Disease Using Nasal Brushings
Christina D. Orru et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1
Shih-Hon Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods
Jianxin Duan et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2010)
Rapid End-Point Quantitation of Prion Seeding Activity with Sensitivity Comparable to Bioassays
Jason M. Wilham et al.
PLOS PATHOGENS (2010)
Prions: Protein Aggregation and Infectious Diseases
Adriano Aguzzi et al.
PHYSIOLOGICAL REVIEWS (2009)
Urinary α1-Antichymotrypsin: A Biomarker of Prion Infection
Gino Miele et al.
PLOS ONE (2008)
Hot spots in prion protein for pathogenic conversion
Kazuo Kuwata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
SERPINA3 (aka alpha-1-antichymotrypsin)
Crystal Baker et al.
FRONTIERS IN BIOSCIENCE (2007)
An overview of the serpin superfamily
Ruby H. P. Law et al.
GENOME BIOLOGY (2006)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Gene expression profiling of scrapie-infected brain tissue
C Riemer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
C Korth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Enhanced levels of scrapie responsive gene mRNA in BSE-infected mouse brain
F Dandoy-Dron et al.
MOLECULAR BRAIN RESEARCH (2000)
Share Paper
